Enveric Biosciences Selects Australian CRO, Avance Clinical, in Preparation for Phase 1 Study of EB-373
EB-373, a proprietary psilocin prodrug, is on track to start its first-in-human clinical trial in the fourth quarter of 2023 CAMBRIDGE, Mass. –Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the…
Read More
Avance Clinical Appoints North America SVP with Global Contract Research Organization, Data Quality and DCT Expertise
Adelaide, Australia | San Diego, USA - Avance Clinical the leading award-winning Australian and North American biotech CRO that offers the GlobalReady program for biotech companies to speed up the…
Read More
Avance Clinical Expands Biometrics Team into India to Support Biotech Trials Demand in US and Australia
Award-winning CRO Avance Clinical, which currently has the largest Biometrics team in Australia, is expanding further with global hires and a specialist hub in Bangalore, India to support growing demand.…
Read More
Avance Clinical Celebrates GlobalReady Success as More Than 40 Biotechs Enter Program
More than 40 biotech clients are now taking advantage of Avance Clinical’s GlobalReady program which delivers streamlined clinical development from early phase in Australia expanding to sites in North America…
Read More
New Analyst Report – Avance Clinical GlobalReady for Biotechs
Avance-Clinical-2022-GlobalReadyDownload
Read More
Avance Clinical Wins Frost & Sullivan Customer Value Leadership Award 2022
Adelaide, Australia/San Diego, USA – After an extensive review by CRO industry analysts comprising executive interviews and background sector research, Frost & Sullivan has recognized Avance Clinical, the leading Australian-based…
Read More
Avance Clinical Sponsors China BioPharma Award at the Global Scrip Awards, London
Adelaide, Australia/San Diego, USA – Avance Clinical, the leading Australian-based biotech CRO with US operations will sponsor and present the China BioPharma Award at the global biotech Scrip Awards in…
Read More
Avance Clinical Wins International Health Award for Biotech CRO Services
Australia – Avance Clinical, the leading Australian-based biotech CRO with US operations has won the South Australian Premier’s Export Awards - International Health category. The award recognises excellence in clinical services exports.…
Read More
AVANCE CLINICAL ANNOUNCES NORTH AMERICAN CRO ACQUISITION TO EXPAND LATER PHASE SERVICES FOR BIOTECHS
https://vimeo.com/746663903 Sydney, Australia/San Diego, USA – Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates to enable…
Read More
Avance Clinical MedTech Featured in Endpoints News – Most read article for the month
Innovative MedTech Demands Specialist Clinical Trial Regulatory Affairs and Design As technology becomes increasingly ubiquitous in our lives, the demand for remote or home-based MedTech for real-time condition detection, monitoring…
Read More
Avance Clinical Featured in Oracle Argus Capabilities Spotlight
Avance Clinical presented real world experience supporting biotech clinical trials using Oracle Argus. Hear from Avance Clinical's Chief Scientific Officer Gabriel Kremmidiotis, and Drug Safety Manager Pilar Garzon in the…
Read More
Avance Clinical Announces at BIO 2022: Expansion Across Australia and New Zealand – New Offices and Double Growth
Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney and Melbourne, with further expansions planned, and increased clinical staff numbers…
Read More
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC
Adelaide, Australia – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC…
Read More
Avance Clinical Announces New Office Opening in Melbourne
Melbourne, Australia – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Melbourne to support its growing clinical team in the…
Read More
Avance Clinical Announces Appointment of Liahna Toy as Head of Business Development
Avance Clinical, the largest full-service Australian Contract Research Organisation (CRO) for international biotechs, announced today the appointment of Liahna Toy to the new senior executive role, Head of Business Development.…
Read More
Brett Favre talks concussion
Listen to football legend Brett Favre on 5AA ‘Rowey’s Sports Show’ talk about concussion in sport and the therapy that leading biotech firm Odyssey Health as in clinical trials with…
Read More
Avance Clinical Announces New Office Opening in Sydney
Sydney, Australia – Avance Clinical, the largest premium Australian Contract Research Organisation (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the…
Read More
Avance Clinical Featured in Endpoints News on Cell & Gene Therapy Capabilities
The cell and gene therapies (CGT) sector offers unprecedented opportunities for patient disease management across virtually all therapeutic areas. However, finding the right accredited clinical teams to take a therapy…
Read More
Avance Clinical Featured in Fierce Biotech on Intranasal Expertise
With the global intranasal drug delivery market estimated to reach up to $71 billion over the next five years, Avance Clinical is seeing an increase in biotech clinical trials targeting…
Read More
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain
Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing of subjects in its first-in-human study…
Read More
Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership
Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC)…
Read More
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia
The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for…
Read More
Avance Clinical Client XWPharma Announces Positive Results from Phase 1 Clinical Trials of XW10172, in Development as Once-Nightly Therapy for Sleep Disorders in Patients with Neurodegenerative Diseases
The leading Australian CRO for international biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client XWPharma on receiving positive results from its Phase 1…
Read More
Avance Clinical Announces Appointment of Asia Biotech Specialist to Support APAC Growth
The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager…
Read More
Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as…
Read More
Avance Clinical at ARCS 2021 Conference
The Avance Clinical team attended the ARCS Annual Conference this week for in-person industry meetings.
Read More
TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020
The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital today that Australia currently has 2,413 trials planned or ongoing. Importantly in Australia, despite the global COVID-19 pandemic,…
Read More
Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as…
Read More
Avance Clinical Releases Industry Survey Results at BIO Korea 2021 – Data Quality the Top Criteria for Selecting a CRO
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a recent industry survey conducted by the company that found data…
Read More
Avance Clinical Wins Excellence in Business Award 2021
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical has won the Fast Movers SA Excellence in Business Award 2021 sponsored by international accounting and business advisory…
Read More
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand…
Read More
Avance Clinical Invited to Present “Decentralized Trials – No Going Back” for Oracle Health Sciences Connect
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle…
Read More
Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the…
Read More
Avance Clinical Joins Industry Leaders at Conference Discussing The Future of Medicinal Cannabis
Australian CRO Avance Clinical Chief Scientific Officer joins industry leaders and Federal Health Minister Greg Hunt today at a conference discussing research opportunities in the fast-growing medicinal cannabis therapeutics sector…
Read More
Avance Clinical Featured in Endpoints News
Is Australia the next Global Destination for Phase 2? According to TrialTrove, there have been 1,411 industry sponsored clinical trials recruiting in Australia and New Zealand since 2019, with 330…
Read More
COVID-19 and the APAC CRO Landscape | Avance Clinical featured in Biospectrum Asia
“Australia has been recognized globally for its handling of the COVID-19 pandemic with strict quarantine systems and advanced contact tracing, resulting in low numbers of cases and deaths. Therefore we…
Read More
News: Avance Clinical Adds Oracle Argus Safety and Pharmacovigilance Platform to its Clinical Technology Solutions
The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has further enhanced its innovative clinical research technology solutions with the addition of…
Read More
AUSTRALIA & ASIA-PACIFIC CRO MARKET REPORT: Frost & Sullivan
Avance Clinical has positioned itself as a global leader in early phase clinical trials by developing innovative strategies and approaches to initial phase development. It helps global biotech companies set…
Read More
ENDPOINTS NEWS: How Innovative Technologies and a Dedicated Site Network is Driving Patient Recruitment for Biotech Clinical Trials in Australia
Australia’s CRO for biotechs, Avance Clinical, deep dives into the patient recruitment landscape identifying the mechanisms and processes that deliver exceptional patient recruitment for early phase trials in Australia. Avance…
Read More
Avance Clinical Client Atossa Therapeutics Completes Enrollment of Phase 1 Clinical Study of AT-301 Nasal Spray Being Developed for the Coronavirus Causing COVID
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to share the news that their client Atossa Therapeutics (NASDAQ: ATOS)…
Read More
Avance Clinical Wins MasterControl 2020 Innovation Excellence Award
The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical today accepted the MasterControl 2020 Innovation Excellence Award in a virtual ceremony. Avance Clinical made…
Read More
Biotechs get scalable early to late phase clinical offering from Cromos Pharma and Avance Clinical collaboration in Australia and Europe
Dublin/Ireland – Adelaide/Australia – Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable…
Read More
News: Avance Clinical ‘ClinicReady’ Featured in Endpoints News
How ClinicReady by Australian CRO Avance Clinical delivers preclinical project management and scientific and regulatory advice to get biotechs into clinic faster Read the full article here
Read More
Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America
The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has expanded its eClinical solutions offering, with advanced digital clinical tools for enhanced…
Read More
News: Jorgen Mould PhD, BSc (Hons) joins Avance Clinical as Scientific Affairs Specialist
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to announce the appointment of Jorgen Mould PhD, BSc (Hons) as…
Read More
Avance Clinical Client Immunic, Inc. Announced Dosing of First Healthy Volunteer in Phase 1 Clinical Program of IMU-856, Targeting Restoration of Intestinal Barrier Function
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to share the news that its client Immunic Therapeutics has announced…
Read More
Avance Clinical Client Atossa Therapeutics Announces Enrollment and Dosing Completed in First Group of Healthy Participants in Clinical Study of AT-301 Nasal Spray Being Developed for Treatment of COVID-19
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to share the news that Atossa Therapeutics have enrolled and…
Read More
Mike Watson Appointed Avance Clinical Director, Business Development, USA
Mike Watson has joined Avance Clinical as Director, Business Development, USA. It is our pleasure to announce that Mike Watson has joined the Avance Clinical team as Director Business Development,…
Read More
Avance Clinical Joins Medrio’s ‘Trial Talks’ Podcast about Why Clinical Trials are Thriving in Australia
The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical, joins Medrio’s new podcast series Trial Talks (listen here https://medrio.com/podcast/why-clinical-trials-are-thriving-in-australia/). Medrio, Inc. is the leading provider…
Read More